Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Albireo Pharma Inc (ALBO)

Albireo Pharma Inc (ALBO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 542,136
  • Shares Outstanding, K 19,362
  • Annual Sales, $ 40,580 K
  • Annual Income, $ -34,030 K
  • 60-Month Beta 0.95
  • Price/Sales 13.41
  • Price/Cash Flow N/A
  • Price/Book 3.09
Trade ALBO with:

Options Overview Details

View History
  • Implied Volatility 88.13% ( -5.52%)
  • Historical Volatility 63.47%
  • IV Percentile 96%
  • IV Rank 66.25%
  • IV High 104.01% on 12/15/21
  • IV Low 56.97% on 11/16/21
  • Put/Call Vol Ratio 2.25
  • Today's Volume 13
  • Volume Avg (30-Day) 140
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 2,964
  • Open Int (30-Day) 3,278

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -2.02
  • Number of Estimates 4
  • High Estimate -2.00
  • Low Estimate -2.05
  • Prior Year -2.29
  • Growth Rate Est. (year over year) +11.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.65 +5.07%
on 05/12/22
37.34 -25.01%
on 04/14/22
-9.29 (-24.91%)
since 04/13/22
3-Month
25.80 +8.53%
on 03/03/22
37.63 -25.59%
on 04/13/22
-4.22 (-13.10%)
since 02/11/22
52-Week
20.30 +37.93%
on 12/15/21
37.86 -26.04%
on 07/20/21
-1.41 (-4.79%)
since 05/13/21

Most Recent Stories

More News
Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Lags Revenue Estimates

Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of -6.52% and 66.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

VRDN : 13.52 (+28.03%)
ALBO : 28.00 (-0.39%)
Exelixis (EXEL) Tops Q1 Earnings Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of 50% and 6.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

EXEL : 20.08 (+1.41%)
ALBO : 28.00 (-0.39%)
Albireo to Report Q1 2022 Financial Results on May 16

Conference call and webcast to be held at 4:30 pm ET...

ALBO : 28.00 (-0.39%)
Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Syndrome

– Phase 3 ASSERT study on track to report topline data by the end of year – Albireo launches Expanded Access Program (EAP) for Alagille syndrome patients ...

ALBO : 28.00 (-0.39%)
Notable Tuesday Option Activity: ALBO, ATSG, PLBY

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Albireo Pharma Inc , where a total volume of 2,031 contracts has been traded thus far...

ALBO : 28.00 (-0.39%)
Albireo Pharma Breaks Below 200-Day Moving Average - Notable for ALBO

In trading on Tuesday, shares of Albireo Pharma Inc crossed below their 200 day moving average of $29.51, changing hands as low as $25.81 per share. Albireo Pharma Inc shares are currently trading off...

ALBO : 28.00 (-0.39%)
Albireo Pharma (ALBO) Reports Q4 Loss, Tops Revenue Estimates

Albireo Pharma (ALBO) delivered earnings and revenue surprises of 55.12% and 164.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ALBO : 28.00 (-0.39%)
WVE : 1.2300 (-4.65%)
Albireo Reports Q4 and Year-End 2021 Financial Results and Business Update

Bylvay™ (odevixibat) launched in the U.S. and Europe, 2021 product revenue, net $7 millionNICE endorses clinical and economic benefits of BylvayPhase 3...

ALBO : 28.00 (-0.39%)
Is a Surprise Coming for Albireo Pharma (ALBO) This Earnings Season?

Albireo Pharma (ALBO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ALBO : 28.00 (-0.39%)
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -19.78% and 33.35%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the...

NTLA : 48.60 (+14.08%)
ALBO : 28.00 (-0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States....

See More

Key Turning Points

3rd Resistance Point 30.38
2nd Resistance Point 29.66
1st Resistance Point 28.83
Last Price 28.00
1st Support Level 27.28
2nd Support Level 26.56
3rd Support Level 25.73

See More

52-Week High 37.86
Fibonacci 61.8% 31.15
Fibonacci 50% 29.08
Last Price 28.00
Fibonacci 38.2% 27.01
52-Week Low 20.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar